![Carlos Garcia-Echeverria](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carlos Garcia-Echeverria
Private Equity Investor chez
Ysios Capital Partners SGEIC SA
Profil
Carlos Garcia-Echeverria is currently a Venture Partner at Ysios Capital Partners SGEIC SA. Formerly, Dr. Garcia-Echeverria was Chief-Rx Creation at EQRx, Inc. from 2021 to 2023 and Executive Director-Oncology Drug Discovery at Novartis AG from 1993 to 2005.
Dr. Garcia-Echeverria earned a doctorate from the University of Barcelona in 1990.
Postes actifs de Carlos Garcia-Echeverria
| Sociétés | Poste | Début |
|---|---|---|
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Private Equity Investor | - |
Anciens postes connus de Carlos Garcia-Echeverria
| Sociétés | Poste | Fin |
|---|---|---|
| EQRX, INC. | Corporate Officer/Principal | 09/11/2023 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2005 |
Formation de Carlos Garcia-Echeverria
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Barcelona
 University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Finance |
EQRx, Inc.
 EQRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers medicines for lung cancer | Health Technology |
